Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.
about
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@en
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@nl
type
label
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@en
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@nl
prefLabel
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@en
Octreotide scintigraphy and Ch ...... ne-refractory prostate cancer.
@nl
P2093
P2860
P356
P1476
Octreotide scintigraphy and Ch ...... one-refractory prostate cancer
@en
P2093
Abrahamsson PA
Elingsbo M
Frederiksen H
Gustavsson B
Kalkner KM
Stridsberg M
Thorsson O
P2860
P2888
P356
10.1038/SJ.PCAN.4500843
P577
2006-01-01T00:00:00Z